Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Accordion Pill carbidopa/levodopa versus immediate-release carbidopa/levodopa in fluctuating Parkinson's disease
2015-003512-20Phase 3Terminated
- Sponsor
- Intec Pharma Ltd.
- Start
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of carbidopa + levodopa in Parkinson's disease (PD) (2 arms), sponsored by Intec Pharma Ltd. Primary endpoint: Change in percentage of daily OFF time during waking hours. Started Mar 2016; status: terminated.
02
Drugs
carbidopa + levodopa
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on 2015-003512-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-003512-20.